nodes	percent_of_prediction	percent_of_DWPC	metapath
Imiquimod—CYP1A2—type 2 diabetes mellitus	0.253	0.602	CbGaD
Imiquimod—CYP3A4—type 2 diabetes mellitus	0.167	0.398	CbGaD
Imiquimod—CYP1A2—Rosiglitazone—type 2 diabetes mellitus	0.038	0.113	CbGbCtD
Imiquimod—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0335	0.0999	CbGbCtD
Imiquimod—CYP1A2—Irbesartan—type 2 diabetes mellitus	0.0299	0.0893	CbGbCtD
Imiquimod—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0299	0.089	CbGbCtD
Imiquimod—CYP1A2—Bromocriptine—type 2 diabetes mellitus	0.0283	0.0844	CbGbCtD
Imiquimod—CYP3A4—Glipizide—type 2 diabetes mellitus	0.0273	0.0814	CbGbCtD
Imiquimod—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.0239	0.0712	CbGbCtD
Imiquimod—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.0216	0.0644	CbGbCtD
Imiquimod—CYP1A2—Losartan—type 2 diabetes mellitus	0.0193	0.0575	CbGbCtD
Imiquimod—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.0164	0.0488	CbGbCtD
Imiquimod—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.0157	0.0468	CbGbCtD
Imiquimod—CYP3A4—Orlistat—type 2 diabetes mellitus	0.0157	0.0468	CbGbCtD
Imiquimod—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.0148	0.0442	CbGbCtD
Imiquimod—CYP3A4—Glyburide—type 2 diabetes mellitus	0.0111	0.0329	CbGbCtD
Imiquimod—CYP3A4—Losartan—type 2 diabetes mellitus	0.0101	0.0301	CbGbCtD
Imiquimod—Headache—Glimepiride—type 2 diabetes mellitus	9.39e-05	0.000495	CcSEcCtD
Imiquimod—Ill-defined disorder—Losartan—type 2 diabetes mellitus	9.38e-05	0.000494	CcSEcCtD
Imiquimod—Cough—Irbesartan—type 2 diabetes mellitus	9.37e-05	0.000494	CcSEcCtD
Imiquimod—Headache—Sitagliptin—type 2 diabetes mellitus	9.36e-05	0.000494	CcSEcCtD
Imiquimod—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	9.29e-05	0.00049	CcSEcCtD
Imiquimod—Agitation—Losartan—type 2 diabetes mellitus	9.29e-05	0.00049	CcSEcCtD
Imiquimod—Oedema—Metformin—type 2 diabetes mellitus	9.29e-05	0.00049	CcSEcCtD
Imiquimod—Tinnitus—Ramipril—type 2 diabetes mellitus	9.28e-05	0.000489	CcSEcCtD
Imiquimod—Hypertension—Irbesartan—type 2 diabetes mellitus	9.27e-05	0.000489	CcSEcCtD
Imiquimod—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	9.25e-05	0.000488	CcSEcCtD
Imiquimod—Flushing—Ramipril—type 2 diabetes mellitus	9.24e-05	0.000487	CcSEcCtD
Imiquimod—Angioedema—Losartan—type 2 diabetes mellitus	9.23e-05	0.000487	CcSEcCtD
Imiquimod—Infection—Metformin—type 2 diabetes mellitus	9.23e-05	0.000487	CcSEcCtD
Imiquimod—Insomnia—Valsartan—type 2 diabetes mellitus	9.22e-05	0.000486	CcSEcCtD
Imiquimod—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	9.18e-05	0.000484	CcSEcCtD
Imiquimod—Paraesthesia—Valsartan—type 2 diabetes mellitus	9.16e-05	0.000483	CcSEcCtD
Imiquimod—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	9.15e-05	0.000482	CcSEcCtD
Imiquimod—Arthralgia—Irbesartan—type 2 diabetes mellitus	9.14e-05	0.000482	CcSEcCtD
Imiquimod—Myalgia—Irbesartan—type 2 diabetes mellitus	9.14e-05	0.000482	CcSEcCtD
Imiquimod—Chest pain—Irbesartan—type 2 diabetes mellitus	9.14e-05	0.000482	CcSEcCtD
Imiquimod—Shock—Metformin—type 2 diabetes mellitus	9.14e-05	0.000482	CcSEcCtD
Imiquimod—Insomnia—Orlistat—type 2 diabetes mellitus	9.11e-05	0.000481	CcSEcCtD
Imiquimod—Malaise—Losartan—type 2 diabetes mellitus	9.11e-05	0.000481	CcSEcCtD
Imiquimod—Anxiety—Irbesartan—type 2 diabetes mellitus	9.11e-05	0.00048	CcSEcCtD
Imiquimod—Hypersensitivity—Glyburide—type 2 diabetes mellitus	9.11e-05	0.00048	CcSEcCtD
Imiquimod—Nervous system disorder—Metformin—type 2 diabetes mellitus	9.11e-05	0.00048	CcSEcCtD
Imiquimod—Dyspnoea—Valsartan—type 2 diabetes mellitus	9.09e-05	0.000479	CcSEcCtD
Imiquimod—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	9.08e-05	0.000479	CcSEcCtD
Imiquimod—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	9.08e-05	0.000479	CcSEcCtD
Imiquimod—Somnolence—Valsartan—type 2 diabetes mellitus	9.07e-05	0.000478	CcSEcCtD
Imiquimod—Syncope—Losartan—type 2 diabetes mellitus	9.06e-05	0.000478	CcSEcCtD
Imiquimod—Paraesthesia—Orlistat—type 2 diabetes mellitus	9.05e-05	0.000477	CcSEcCtD
Imiquimod—Discomfort—Irbesartan—type 2 diabetes mellitus	9.03e-05	0.000476	CcSEcCtD
Imiquimod—Skin disorder—Metformin—type 2 diabetes mellitus	9.02e-05	0.000476	CcSEcCtD
Imiquimod—Immune system disorder—Ramipril—type 2 diabetes mellitus	8.99e-05	0.000474	CcSEcCtD
Imiquimod—Hyperhidrosis—Metformin—type 2 diabetes mellitus	8.98e-05	0.000473	CcSEcCtD
Imiquimod—Dyspepsia—Valsartan—type 2 diabetes mellitus	8.98e-05	0.000473	CcSEcCtD
Imiquimod—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	8.97e-05	0.000473	CcSEcCtD
Imiquimod—Dizziness—Bromocriptine—type 2 diabetes mellitus	8.94e-05	0.000472	CcSEcCtD
Imiquimod—Dry mouth—Irbesartan—type 2 diabetes mellitus	8.94e-05	0.000472	CcSEcCtD
Imiquimod—Palpitations—Losartan—type 2 diabetes mellitus	8.93e-05	0.000471	CcSEcCtD
Imiquimod—Nausea—Glimepiride—type 2 diabetes mellitus	8.9e-05	0.00047	CcSEcCtD
Imiquimod—Arrhythmia—Ramipril—type 2 diabetes mellitus	8.89e-05	0.000469	CcSEcCtD
Imiquimod—Loss of consciousness—Losartan—type 2 diabetes mellitus	8.88e-05	0.000468	CcSEcCtD
Imiquimod—Nausea—Sitagliptin—type 2 diabetes mellitus	8.88e-05	0.000468	CcSEcCtD
Imiquimod—Dyspepsia—Orlistat—type 2 diabetes mellitus	8.87e-05	0.000468	CcSEcCtD
Imiquimod—Asthenia—Glyburide—type 2 diabetes mellitus	8.87e-05	0.000468	CcSEcCtD
Imiquimod—Decreased appetite—Valsartan—type 2 diabetes mellitus	8.87e-05	0.000468	CcSEcCtD
Imiquimod—Anorexia—Metformin—type 2 diabetes mellitus	8.85e-05	0.000467	CcSEcCtD
Imiquimod—Cough—Losartan—type 2 diabetes mellitus	8.82e-05	0.000465	CcSEcCtD
Imiquimod—Urticaria—Gliclazide—type 2 diabetes mellitus	8.82e-05	0.000465	CcSEcCtD
Imiquimod—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	8.8e-05	0.000464	CcSEcCtD
Imiquimod—Alopecia—Ramipril—type 2 diabetes mellitus	8.8e-05	0.000464	CcSEcCtD
Imiquimod—Fatigue—Valsartan—type 2 diabetes mellitus	8.79e-05	0.000464	CcSEcCtD
Imiquimod—Body temperature increased—Gliclazide—type 2 diabetes mellitus	8.77e-05	0.000463	CcSEcCtD
Imiquimod—Abdominal pain—Gliclazide—type 2 diabetes mellitus	8.77e-05	0.000463	CcSEcCtD
Imiquimod—Oedema—Irbesartan—type 2 diabetes mellitus	8.76e-05	0.000462	CcSEcCtD
Imiquimod—Decreased appetite—Orlistat—type 2 diabetes mellitus	8.76e-05	0.000462	CcSEcCtD
Imiquimod—Pruritus—Glyburide—type 2 diabetes mellitus	8.75e-05	0.000461	CcSEcCtD
Imiquimod—Mental disorder—Ramipril—type 2 diabetes mellitus	8.72e-05	0.00046	CcSEcCtD
Imiquimod—Infection—Irbesartan—type 2 diabetes mellitus	8.71e-05	0.000459	CcSEcCtD
Imiquimod—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	8.7e-05	0.000459	CcSEcCtD
Imiquimod—Fatigue—Orlistat—type 2 diabetes mellitus	8.69e-05	0.000458	CcSEcCtD
Imiquimod—Erythema—Ramipril—type 2 diabetes mellitus	8.67e-05	0.000457	CcSEcCtD
Imiquimod—Malnutrition—Ramipril—type 2 diabetes mellitus	8.67e-05	0.000457	CcSEcCtD
Imiquimod—Shock—Irbesartan—type 2 diabetes mellitus	8.62e-05	0.000455	CcSEcCtD
Imiquimod—Pain—Orlistat—type 2 diabetes mellitus	8.62e-05	0.000454	CcSEcCtD
Imiquimod—Arthralgia—Losartan—type 2 diabetes mellitus	8.6e-05	0.000454	CcSEcCtD
Imiquimod—Chest pain—Losartan—type 2 diabetes mellitus	8.6e-05	0.000454	CcSEcCtD
Imiquimod—Myalgia—Losartan—type 2 diabetes mellitus	8.6e-05	0.000454	CcSEcCtD
Imiquimod—Vomiting—Bromocriptine—type 2 diabetes mellitus	8.6e-05	0.000453	CcSEcCtD
Imiquimod—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	8.59e-05	0.000453	CcSEcCtD
Imiquimod—Anxiety—Losartan—type 2 diabetes mellitus	8.57e-05	0.000452	CcSEcCtD
Imiquimod—Tachycardia—Irbesartan—type 2 diabetes mellitus	8.55e-05	0.000451	CcSEcCtD
Imiquimod—Rash—Bromocriptine—type 2 diabetes mellitus	8.53e-05	0.00045	CcSEcCtD
Imiquimod—Dermatitis—Bromocriptine—type 2 diabetes mellitus	8.52e-05	0.000449	CcSEcCtD
Imiquimod—Skin disorder—Irbesartan—type 2 diabetes mellitus	8.51e-05	0.000449	CcSEcCtD
Imiquimod—Discomfort—Losartan—type 2 diabetes mellitus	8.5e-05	0.000448	CcSEcCtD
Imiquimod—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	8.47e-05	0.000447	CcSEcCtD
Imiquimod—Headache—Bromocriptine—type 2 diabetes mellitus	8.47e-05	0.000447	CcSEcCtD
Imiquimod—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	8.46e-05	0.000446	CcSEcCtD
Imiquimod—Diarrhoea—Glyburide—type 2 diabetes mellitus	8.46e-05	0.000446	CcSEcCtD
Imiquimod—Dry mouth—Losartan—type 2 diabetes mellitus	8.41e-05	0.000444	CcSEcCtD
Imiquimod—Anorexia—Irbesartan—type 2 diabetes mellitus	8.35e-05	0.000441	CcSEcCtD
Imiquimod—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	8.34e-05	0.00044	CcSEcCtD
Imiquimod—Paraesthesia—Metformin—type 2 diabetes mellitus	8.34e-05	0.00044	CcSEcCtD
Imiquimod—Feeling abnormal—Orlistat—type 2 diabetes mellitus	8.3e-05	0.000438	CcSEcCtD
Imiquimod—Dyspnoea—Metformin—type 2 diabetes mellitus	8.28e-05	0.000437	CcSEcCtD
Imiquimod—Somnolence—Metformin—type 2 diabetes mellitus	8.26e-05	0.000435	CcSEcCtD
Imiquimod—Oedema—Losartan—type 2 diabetes mellitus	8.25e-05	0.000435	CcSEcCtD
Imiquimod—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	8.24e-05	0.000435	CcSEcCtD
Imiquimod—Infection—Losartan—type 2 diabetes mellitus	8.19e-05	0.000432	CcSEcCtD
Imiquimod—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	8.18e-05	0.000431	CcSEcCtD
Imiquimod—Dyspepsia—Metformin—type 2 diabetes mellitus	8.18e-05	0.000431	CcSEcCtD
Imiquimod—Shock—Losartan—type 2 diabetes mellitus	8.11e-05	0.000428	CcSEcCtD
Imiquimod—Urticaria—Valsartan—type 2 diabetes mellitus	8.1e-05	0.000427	CcSEcCtD
Imiquimod—Nervous system disorder—Losartan—type 2 diabetes mellitus	8.09e-05	0.000427	CcSEcCtD
Imiquimod—Decreased appetite—Metformin—type 2 diabetes mellitus	8.07e-05	0.000426	CcSEcCtD
Imiquimod—Abdominal pain—Valsartan—type 2 diabetes mellitus	8.06e-05	0.000425	CcSEcCtD
Imiquimod—Tachycardia—Losartan—type 2 diabetes mellitus	8.05e-05	0.000425	CcSEcCtD
Imiquimod—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	8.04e-05	0.000424	CcSEcCtD
Imiquimod—Nausea—Bromocriptine—type 2 diabetes mellitus	8.03e-05	0.000424	CcSEcCtD
Imiquimod—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	8.02e-05	0.000423	CcSEcCtD
Imiquimod—Fatigue—Metformin—type 2 diabetes mellitus	8.01e-05	0.000422	CcSEcCtD
Imiquimod—Urticaria—Orlistat—type 2 diabetes mellitus	8.01e-05	0.000422	CcSEcCtD
Imiquimod—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	7.99e-05	0.000421	CcSEcCtD
Imiquimod—Hyperhidrosis—Losartan—type 2 diabetes mellitus	7.97e-05	0.00042	CcSEcCtD
Imiquimod—Abdominal pain—Orlistat—type 2 diabetes mellitus	7.97e-05	0.00042	CcSEcCtD
Imiquimod—Body temperature increased—Orlistat—type 2 diabetes mellitus	7.97e-05	0.00042	CcSEcCtD
Imiquimod—Asthenia—Gliclazide—type 2 diabetes mellitus	7.96e-05	0.00042	CcSEcCtD
Imiquimod—Agitation—Ramipril—type 2 diabetes mellitus	7.96e-05	0.00042	CcSEcCtD
Imiquimod—Angioedema—Ramipril—type 2 diabetes mellitus	7.92e-05	0.000418	CcSEcCtD
Imiquimod—Paraesthesia—Irbesartan—type 2 diabetes mellitus	7.87e-05	0.000415	CcSEcCtD
Imiquimod—Anorexia—Losartan—type 2 diabetes mellitus	7.86e-05	0.000415	CcSEcCtD
Imiquimod—Vomiting—Glyburide—type 2 diabetes mellitus	7.86e-05	0.000414	CcSEcCtD
Imiquimod—Pruritus—Gliclazide—type 2 diabetes mellitus	7.85e-05	0.000414	CcSEcCtD
Imiquimod—Malaise—Ramipril—type 2 diabetes mellitus	7.81e-05	0.000412	CcSEcCtD
Imiquimod—Dyspnoea—Irbesartan—type 2 diabetes mellitus	7.81e-05	0.000412	CcSEcCtD
Imiquimod—Rash—Glyburide—type 2 diabetes mellitus	7.79e-05	0.000411	CcSEcCtD
Imiquimod—Somnolence—Irbesartan—type 2 diabetes mellitus	7.79e-05	0.000411	CcSEcCtD
Imiquimod—Dermatitis—Glyburide—type 2 diabetes mellitus	7.79e-05	0.000411	CcSEcCtD
Imiquimod—Syncope—Ramipril—type 2 diabetes mellitus	7.77e-05	0.00041	CcSEcCtD
Imiquimod—Headache—Glyburide—type 2 diabetes mellitus	7.74e-05	0.000408	CcSEcCtD
Imiquimod—Dyspepsia—Irbesartan—type 2 diabetes mellitus	7.71e-05	0.000407	CcSEcCtD
Imiquimod—Palpitations—Ramipril—type 2 diabetes mellitus	7.66e-05	0.000404	CcSEcCtD
Imiquimod—Feeling abnormal—Metformin—type 2 diabetes mellitus	7.65e-05	0.000404	CcSEcCtD
Imiquimod—Decreased appetite—Irbesartan—type 2 diabetes mellitus	7.62e-05	0.000402	CcSEcCtD
Imiquimod—Loss of consciousness—Ramipril—type 2 diabetes mellitus	7.62e-05	0.000402	CcSEcCtD
Imiquimod—Diarrhoea—Gliclazide—type 2 diabetes mellitus	7.59e-05	0.000401	CcSEcCtD
Imiquimod—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	7.59e-05	0.0004	CcSEcCtD
Imiquimod—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	7.57e-05	0.000399	CcSEcCtD
Imiquimod—Cough—Ramipril—type 2 diabetes mellitus	7.56e-05	0.000399	CcSEcCtD
Imiquimod—Fatigue—Irbesartan—type 2 diabetes mellitus	7.56e-05	0.000398	CcSEcCtD
Imiquimod—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	7.51e-05	0.000396	CcSEcCtD
Imiquimod—Hypersensitivity—Valsartan—type 2 diabetes mellitus	7.51e-05	0.000396	CcSEcCtD
Imiquimod—Convulsion—Ramipril—type 2 diabetes mellitus	7.51e-05	0.000396	CcSEcCtD
Imiquimod—Pain—Irbesartan—type 2 diabetes mellitus	7.49e-05	0.000395	CcSEcCtD
Imiquimod—Insomnia—Losartan—type 2 diabetes mellitus	7.46e-05	0.000393	CcSEcCtD
Imiquimod—Hypersensitivity—Orlistat—type 2 diabetes mellitus	7.42e-05	0.000392	CcSEcCtD
Imiquimod—Paraesthesia—Losartan—type 2 diabetes mellitus	7.41e-05	0.000391	CcSEcCtD
Imiquimod—Urticaria—Metformin—type 2 diabetes mellitus	7.38e-05	0.000389	CcSEcCtD
Imiquimod—Chest pain—Ramipril—type 2 diabetes mellitus	7.38e-05	0.000389	CcSEcCtD
Imiquimod—Myalgia—Ramipril—type 2 diabetes mellitus	7.38e-05	0.000389	CcSEcCtD
Imiquimod—Arthralgia—Ramipril—type 2 diabetes mellitus	7.38e-05	0.000389	CcSEcCtD
Imiquimod—Dyspnoea—Losartan—type 2 diabetes mellitus	7.35e-05	0.000388	CcSEcCtD
Imiquimod—Anxiety—Ramipril—type 2 diabetes mellitus	7.35e-05	0.000388	CcSEcCtD
Imiquimod—Nausea—Glyburide—type 2 diabetes mellitus	7.34e-05	0.000387	CcSEcCtD
Imiquimod—Abdominal pain—Metformin—type 2 diabetes mellitus	7.34e-05	0.000387	CcSEcCtD
Imiquimod—Dizziness—Gliclazide—type 2 diabetes mellitus	7.34e-05	0.000387	CcSEcCtD
Imiquimod—Somnolence—Losartan—type 2 diabetes mellitus	7.33e-05	0.000387	CcSEcCtD
Imiquimod—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	7.33e-05	0.000386	CcSEcCtD
Imiquimod—Asthenia—Valsartan—type 2 diabetes mellitus	7.32e-05	0.000386	CcSEcCtD
Imiquimod—Discomfort—Ramipril—type 2 diabetes mellitus	7.29e-05	0.000384	CcSEcCtD
Imiquimod—Dyspepsia—Losartan—type 2 diabetes mellitus	7.26e-05	0.000383	CcSEcCtD
Imiquimod—Asthenia—Orlistat—type 2 diabetes mellitus	7.23e-05	0.000381	CcSEcCtD
Imiquimod—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	7.22e-05	0.000381	CcSEcCtD
Imiquimod—Pruritus—Valsartan—type 2 diabetes mellitus	7.22e-05	0.00038	CcSEcCtD
Imiquimod—Dry mouth—Ramipril—type 2 diabetes mellitus	7.22e-05	0.00038	CcSEcCtD
Imiquimod—Decreased appetite—Losartan—type 2 diabetes mellitus	7.17e-05	0.000378	CcSEcCtD
Imiquimod—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	7.17e-05	0.000378	CcSEcCtD
Imiquimod—Pruritus—Orlistat—type 2 diabetes mellitus	7.13e-05	0.000376	CcSEcCtD
Imiquimod—Fatigue—Losartan—type 2 diabetes mellitus	7.11e-05	0.000375	CcSEcCtD
Imiquimod—Oedema—Ramipril—type 2 diabetes mellitus	7.07e-05	0.000373	CcSEcCtD
Imiquimod—Vomiting—Gliclazide—type 2 diabetes mellitus	7.06e-05	0.000372	CcSEcCtD
Imiquimod—Pain—Losartan—type 2 diabetes mellitus	7.05e-05	0.000372	CcSEcCtD
Imiquimod—Rash—Gliclazide—type 2 diabetes mellitus	7e-05	0.000369	CcSEcCtD
Imiquimod—Dermatitis—Gliclazide—type 2 diabetes mellitus	6.99e-05	0.000369	CcSEcCtD
Imiquimod—Diarrhoea—Valsartan—type 2 diabetes mellitus	6.98e-05	0.000368	CcSEcCtD
Imiquimod—Urticaria—Irbesartan—type 2 diabetes mellitus	6.96e-05	0.000367	CcSEcCtD
Imiquimod—Shock—Ramipril—type 2 diabetes mellitus	6.96e-05	0.000367	CcSEcCtD
Imiquimod—Headache—Gliclazide—type 2 diabetes mellitus	6.95e-05	0.000367	CcSEcCtD
Imiquimod—Nervous system disorder—Ramipril—type 2 diabetes mellitus	6.94e-05	0.000366	CcSEcCtD
Imiquimod—Body temperature increased—Irbesartan—type 2 diabetes mellitus	6.93e-05	0.000365	CcSEcCtD
Imiquimod—Abdominal pain—Irbesartan—type 2 diabetes mellitus	6.93e-05	0.000365	CcSEcCtD
Imiquimod—Tachycardia—Ramipril—type 2 diabetes mellitus	6.9e-05	0.000364	CcSEcCtD
Imiquimod—Diarrhoea—Orlistat—type 2 diabetes mellitus	6.9e-05	0.000364	CcSEcCtD
Imiquimod—Skin disorder—Ramipril—type 2 diabetes mellitus	6.87e-05	0.000362	CcSEcCtD
Imiquimod—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	6.84e-05	0.000361	CcSEcCtD
Imiquimod—Feeling abnormal—Losartan—type 2 diabetes mellitus	6.8e-05	0.000358	CcSEcCtD
Imiquimod—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	6.74e-05	0.000356	CcSEcCtD
Imiquimod—Dizziness—Valsartan—type 2 diabetes mellitus	6.74e-05	0.000356	CcSEcCtD
Imiquimod—Anorexia—Ramipril—type 2 diabetes mellitus	6.74e-05	0.000356	CcSEcCtD
Imiquimod—Dizziness—Orlistat—type 2 diabetes mellitus	6.66e-05	0.000351	CcSEcCtD
Imiquimod—Asthenia—Metformin—type 2 diabetes mellitus	6.66e-05	0.000351	CcSEcCtD
Imiquimod—Nausea—Gliclazide—type 2 diabetes mellitus	6.59e-05	0.000348	CcSEcCtD
Imiquimod—Pruritus—Metformin—type 2 diabetes mellitus	6.57e-05	0.000346	CcSEcCtD
Imiquimod—Urticaria—Losartan—type 2 diabetes mellitus	6.55e-05	0.000346	CcSEcCtD
Imiquimod—Abdominal pain—Losartan—type 2 diabetes mellitus	6.52e-05	0.000344	CcSEcCtD
Imiquimod—Body temperature increased—Losartan—type 2 diabetes mellitus	6.52e-05	0.000344	CcSEcCtD
Imiquimod—Vomiting—Valsartan—type 2 diabetes mellitus	6.48e-05	0.000342	CcSEcCtD
Imiquimod—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	6.46e-05	0.000341	CcSEcCtD
Imiquimod—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	6.44e-05	0.00034	CcSEcCtD
Imiquimod—Rash—Valsartan—type 2 diabetes mellitus	6.43e-05	0.000339	CcSEcCtD
Imiquimod—Dermatitis—Valsartan—type 2 diabetes mellitus	6.42e-05	0.000339	CcSEcCtD
Imiquimod—Vomiting—Orlistat—type 2 diabetes mellitus	6.41e-05	0.000338	CcSEcCtD
Imiquimod—Insomnia—Ramipril—type 2 diabetes mellitus	6.4e-05	0.000337	CcSEcCtD
Imiquimod—Headache—Valsartan—type 2 diabetes mellitus	6.39e-05	0.000337	CcSEcCtD
Imiquimod—Diarrhoea—Metformin—type 2 diabetes mellitus	6.35e-05	0.000335	CcSEcCtD
Imiquimod—Rash—Orlistat—type 2 diabetes mellitus	6.35e-05	0.000335	CcSEcCtD
Imiquimod—Paraesthesia—Ramipril—type 2 diabetes mellitus	6.35e-05	0.000335	CcSEcCtD
Imiquimod—Dermatitis—Orlistat—type 2 diabetes mellitus	6.35e-05	0.000335	CcSEcCtD
Imiquimod—Headache—Orlistat—type 2 diabetes mellitus	6.31e-05	0.000333	CcSEcCtD
Imiquimod—Dyspnoea—Ramipril—type 2 diabetes mellitus	6.31e-05	0.000333	CcSEcCtD
Imiquimod—Asthenia—Irbesartan—type 2 diabetes mellitus	6.29e-05	0.000332	CcSEcCtD
Imiquimod—Somnolence—Ramipril—type 2 diabetes mellitus	6.29e-05	0.000332	CcSEcCtD
Imiquimod—Dyspepsia—Ramipril—type 2 diabetes mellitus	6.23e-05	0.000328	CcSEcCtD
Imiquimod—Pruritus—Irbesartan—type 2 diabetes mellitus	6.2e-05	0.000327	CcSEcCtD
Imiquimod—Decreased appetite—Ramipril—type 2 diabetes mellitus	6.15e-05	0.000324	CcSEcCtD
Imiquimod—Dizziness—Metformin—type 2 diabetes mellitus	6.14e-05	0.000324	CcSEcCtD
Imiquimod—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	6.11e-05	0.000322	CcSEcCtD
Imiquimod—Fatigue—Ramipril—type 2 diabetes mellitus	6.1e-05	0.000322	CcSEcCtD
Imiquimod—Hypersensitivity—Losartan—type 2 diabetes mellitus	6.08e-05	0.00032	CcSEcCtD
Imiquimod—Nausea—Valsartan—type 2 diabetes mellitus	6.06e-05	0.000319	CcSEcCtD
Imiquimod—Diarrhoea—Irbesartan—type 2 diabetes mellitus	6e-05	0.000316	CcSEcCtD
Imiquimod—Nausea—Orlistat—type 2 diabetes mellitus	5.99e-05	0.000316	CcSEcCtD
Imiquimod—Asthenia—Losartan—type 2 diabetes mellitus	5.92e-05	0.000312	CcSEcCtD
Imiquimod—Vomiting—Metformin—type 2 diabetes mellitus	5.9e-05	0.000311	CcSEcCtD
Imiquimod—Rash—Metformin—type 2 diabetes mellitus	5.86e-05	0.000309	CcSEcCtD
Imiquimod—Dermatitis—Metformin—type 2 diabetes mellitus	5.85e-05	0.000309	CcSEcCtD
Imiquimod—Pruritus—Losartan—type 2 diabetes mellitus	5.84e-05	0.000308	CcSEcCtD
Imiquimod—Feeling abnormal—Ramipril—type 2 diabetes mellitus	5.83e-05	0.000307	CcSEcCtD
Imiquimod—Headache—Metformin—type 2 diabetes mellitus	5.82e-05	0.000307	CcSEcCtD
Imiquimod—Dizziness—Irbesartan—type 2 diabetes mellitus	5.8e-05	0.000306	CcSEcCtD
Imiquimod—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	5.78e-05	0.000305	CcSEcCtD
Imiquimod—Diarrhoea—Losartan—type 2 diabetes mellitus	5.64e-05	0.000298	CcSEcCtD
Imiquimod—Urticaria—Ramipril—type 2 diabetes mellitus	5.62e-05	0.000296	CcSEcCtD
Imiquimod—Abdominal pain—Ramipril—type 2 diabetes mellitus	5.59e-05	0.000295	CcSEcCtD
Imiquimod—Body temperature increased—Ramipril—type 2 diabetes mellitus	5.59e-05	0.000295	CcSEcCtD
Imiquimod—Vomiting—Irbesartan—type 2 diabetes mellitus	5.57e-05	0.000294	CcSEcCtD
Imiquimod—Rash—Irbesartan—type 2 diabetes mellitus	5.53e-05	0.000291	CcSEcCtD
Imiquimod—Dermatitis—Irbesartan—type 2 diabetes mellitus	5.52e-05	0.000291	CcSEcCtD
Imiquimod—Nausea—Metformin—type 2 diabetes mellitus	5.52e-05	0.000291	CcSEcCtD
Imiquimod—Headache—Irbesartan—type 2 diabetes mellitus	5.49e-05	0.00029	CcSEcCtD
Imiquimod—Dizziness—Losartan—type 2 diabetes mellitus	5.45e-05	0.000288	CcSEcCtD
Imiquimod—Vomiting—Losartan—type 2 diabetes mellitus	5.24e-05	0.000277	CcSEcCtD
Imiquimod—Hypersensitivity—Ramipril—type 2 diabetes mellitus	5.21e-05	0.000275	CcSEcCtD
Imiquimod—Nausea—Irbesartan—type 2 diabetes mellitus	5.21e-05	0.000275	CcSEcCtD
Imiquimod—Rash—Losartan—type 2 diabetes mellitus	5.2e-05	0.000274	CcSEcCtD
Imiquimod—Dermatitis—Losartan—type 2 diabetes mellitus	5.2e-05	0.000274	CcSEcCtD
Imiquimod—Headache—Losartan—type 2 diabetes mellitus	5.17e-05	0.000272	CcSEcCtD
Imiquimod—TLR8—Immune System—BCL2—type 2 diabetes mellitus	5.1e-05	0.000933	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—SRC—type 2 diabetes mellitus	5.1e-05	0.000933	CbGpPWpGaD
Imiquimod—Asthenia—Ramipril—type 2 diabetes mellitus	5.07e-05	0.000268	CcSEcCtD
Imiquimod—CYP1A2—Phase II conjugation—GSTM1—type 2 diabetes mellitus	5.07e-05	0.000928	CbGpPWpGaD
Imiquimod—TLR7—Immune System—PRKCB—type 2 diabetes mellitus	5.05e-05	0.000924	CbGpPWpGaD
Imiquimod—TLR7—Immune System—ICAM1—type 2 diabetes mellitus	5.03e-05	0.000921	CbGpPWpGaD
Imiquimod—Pruritus—Ramipril—type 2 diabetes mellitus	5e-05	0.000264	CcSEcCtD
Imiquimod—TLR8—Immune System—RELA—type 2 diabetes mellitus	4.99e-05	0.000912	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—RELA—type 2 diabetes mellitus	4.94e-05	0.000904	CbGpPWpGaD
Imiquimod—Nausea—Losartan—type 2 diabetes mellitus	4.9e-05	0.000258	CcSEcCtD
Imiquimod—CYP1A2—Biological oxidations—MTR—type 2 diabetes mellitus	4.9e-05	0.000896	CbGpPWpGaD
Imiquimod—Diarrhoea—Ramipril—type 2 diabetes mellitus	4.84e-05	0.000255	CcSEcCtD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—type 2 diabetes mellitus	4.8e-05	0.000879	CbGpPWpGaD
Imiquimod—TLR7—Immune System—IRS1—type 2 diabetes mellitus	4.78e-05	0.000874	CbGpPWpGaD
Imiquimod—CYP1A2—Biological oxidations—CYP11A1—type 2 diabetes mellitus	4.74e-05	0.000867	CbGpPWpGaD
Imiquimod—CYP1A2—Metapathway biotransformation—CYP11A1—type 2 diabetes mellitus	4.68e-05	0.000856	CbGpPWpGaD
Imiquimod—Dizziness—Ramipril—type 2 diabetes mellitus	4.68e-05	0.000247	CcSEcCtD
Imiquimod—TLR8—Innate Immune System—IL6—type 2 diabetes mellitus	4.53e-05	0.000829	CbGpPWpGaD
Imiquimod—TLR7—Immune System—CASP8—type 2 diabetes mellitus	4.5e-05	0.000824	CbGpPWpGaD
Imiquimod—Vomiting—Ramipril—type 2 diabetes mellitus	4.5e-05	0.000237	CcSEcCtD
Imiquimod—CYP1A2—Arachidonic acid metabolism—PTGS2—type 2 diabetes mellitus	4.49e-05	0.000822	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—EGFR—type 2 diabetes mellitus	4.47e-05	0.000817	CbGpPWpGaD
Imiquimod—Rash—Ramipril—type 2 diabetes mellitus	4.46e-05	0.000235	CcSEcCtD
Imiquimod—Dermatitis—Ramipril—type 2 diabetes mellitus	4.46e-05	0.000235	CcSEcCtD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—PTGDS—type 2 diabetes mellitus	4.44e-05	0.000812	CbGpPWpGaD
Imiquimod—Headache—Ramipril—type 2 diabetes mellitus	4.43e-05	0.000234	CcSEcCtD
Imiquimod—TLR7—Immune System—AKT2—type 2 diabetes mellitus	4.43e-05	0.000809	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—GPD2—type 2 diabetes mellitus	4.21e-05	0.00077	CbGpPWpGaD
Imiquimod—TLR8—Immune System—NFKB1—type 2 diabetes mellitus	4.21e-05	0.000769	CbGpPWpGaD
Imiquimod—Nausea—Ramipril—type 2 diabetes mellitus	4.2e-05	0.000222	CcSEcCtD
Imiquimod—TLR8—Innate Immune System—AKT1—type 2 diabetes mellitus	4.18e-05	0.000765	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—type 2 diabetes mellitus	4.17e-05	0.000763	CbGpPWpGaD
Imiquimod—TLR7—Immune System—PIK3R1—type 2 diabetes mellitus	4.02e-05	0.000734	CbGpPWpGaD
Imiquimod—TLR8—Immune System—SRC—type 2 diabetes mellitus	3.92e-05	0.000717	CbGpPWpGaD
Imiquimod—CYP1A2—Biological oxidations—CYP2E1—type 2 diabetes mellitus	3.91e-05	0.000716	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—SRC—type 2 diabetes mellitus	3.89e-05	0.000711	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—type 2 diabetes mellitus	3.89e-05	0.000711	CbGpPWpGaD
Imiquimod—TLR7—Immune System—BCL2—type 2 diabetes mellitus	3.87e-05	0.000707	CbGpPWpGaD
Imiquimod—CYP1A2—Metapathway biotransformation—CYP2E1—type 2 diabetes mellitus	3.86e-05	0.000706	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—type 2 diabetes mellitus	3.78e-05	0.000692	CbGpPWpGaD
Imiquimod—TLR7—Immune System—RELA—type 2 diabetes mellitus	3.78e-05	0.000691	CbGpPWpGaD
Imiquimod—CYP3A4—Biological oxidations—MTR—type 2 diabetes mellitus	3.78e-05	0.000691	CbGpPWpGaD
Imiquimod—CYP1A2—Biological oxidations—CYP3A4—type 2 diabetes mellitus	3.77e-05	0.00069	CbGpPWpGaD
Imiquimod—CYP1A2—Metapathway biotransformation—CYP3A4—type 2 diabetes mellitus	3.72e-05	0.000681	CbGpPWpGaD
Imiquimod—CYP3A4—Biological oxidations—CYP11A1—type 2 diabetes mellitus	3.66e-05	0.000669	CbGpPWpGaD
Imiquimod—CYP3A4—Metapathway biotransformation—CYP11A1—type 2 diabetes mellitus	3.61e-05	0.00066	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—type 2 diabetes mellitus	3.47e-05	0.000635	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—IL6—type 2 diabetes mellitus	3.43e-05	0.000628	CbGpPWpGaD
Imiquimod—TLR8—Immune System—EGFR—type 2 diabetes mellitus	3.43e-05	0.000628	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—type 2 diabetes mellitus	3.41e-05	0.000623	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—type 2 diabetes mellitus	3.41e-05	0.000623	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—OXCT1—type 2 diabetes mellitus	3.27e-05	0.000599	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—type 2 diabetes mellitus	3.24e-05	0.000593	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—TNF—type 2 diabetes mellitus	3.24e-05	0.000593	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—SRD5A1—type 2 diabetes mellitus	3.19e-05	0.000584	CbGpPWpGaD
Imiquimod—TLR7—Immune System—NFKB1—type 2 diabetes mellitus	3.19e-05	0.000583	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—AKT1—type 2 diabetes mellitus	3.17e-05	0.00058	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—STAR—type 2 diabetes mellitus	3.04e-05	0.000557	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—ACACA—type 2 diabetes mellitus	3.04e-05	0.000557	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—HSD17B3—type 2 diabetes mellitus	3.04e-05	0.000557	CbGpPWpGaD
Imiquimod—CYP3A4—Biological oxidations—CYP2E1—type 2 diabetes mellitus	3.02e-05	0.000553	CbGpPWpGaD
Imiquimod—CYP3A4—Biological oxidations—CYP1A2—type 2 diabetes mellitus	2.99e-05	0.000546	CbGpPWpGaD
Imiquimod—CYP3A4—Metapathway biotransformation—CYP2E1—type 2 diabetes mellitus	2.98e-05	0.000545	CbGpPWpGaD
Imiquimod—TLR7—Immune System—SRC—type 2 diabetes mellitus	2.97e-05	0.000543	CbGpPWpGaD
Imiquimod—CYP1A2—Biological oxidations—GSTM1—type 2 diabetes mellitus	2.97e-05	0.000543	CbGpPWpGaD
Imiquimod—CYP3A4—Metapathway biotransformation—CYP1A2—type 2 diabetes mellitus	2.95e-05	0.000539	CbGpPWpGaD
Imiquimod—CYP1A2—Metapathway biotransformation—GSTM1—type 2 diabetes mellitus	2.93e-05	0.000535	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—NCOA6—type 2 diabetes mellitus	2.76e-05	0.000505	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—HSD11B1—type 2 diabetes mellitus	2.71e-05	0.000496	CbGpPWpGaD
Imiquimod—TLR8—Immune System—IL6—type 2 diabetes mellitus	2.64e-05	0.000483	CbGpPWpGaD
Imiquimod—TLR7—Immune System—EGFR—type 2 diabetes mellitus	2.6e-05	0.000476	CbGpPWpGaD
Imiquimod—TLR8—Immune System—AKT1—type 2 diabetes mellitus	2.44e-05	0.000445	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—LPA—type 2 diabetes mellitus	2.31e-05	0.000422	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—HSD3B2—type 2 diabetes mellitus	2.31e-05	0.000422	CbGpPWpGaD
Imiquimod—CYP3A4—Biological oxidations—GSTM1—type 2 diabetes mellitus	2.29e-05	0.000419	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—BHMT—type 2 diabetes mellitus	2.26e-05	0.000414	CbGpPWpGaD
Imiquimod—CYP3A4—Metapathway biotransformation—GSTM1—type 2 diabetes mellitus	2.26e-05	0.000413	CbGpPWpGaD
Imiquimod—TLR7—Immune System—IL6—type 2 diabetes mellitus	2e-05	0.000366	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—AANAT—type 2 diabetes mellitus	1.98e-05	0.000362	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—PTGDS—type 2 diabetes mellitus	1.98e-05	0.000362	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—CPT1A—type 2 diabetes mellitus	1.88e-05	0.000344	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—CDO1—type 2 diabetes mellitus	1.87e-05	0.000343	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—GPD2—type 2 diabetes mellitus	1.87e-05	0.000343	CbGpPWpGaD
Imiquimod—TLR7—Immune System—AKT1—type 2 diabetes mellitus	1.85e-05	0.000338	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—LIPC—type 2 diabetes mellitus	1.83e-05	0.000335	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—type 2 diabetes mellitus	1.82e-05	0.000333	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—AK1—type 2 diabetes mellitus	1.79e-05	0.000327	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—CETP—type 2 diabetes mellitus	1.77e-05	0.000323	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—BHMT—type 2 diabetes mellitus	1.75e-05	0.000319	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—SLC5A4—type 2 diabetes mellitus	1.65e-05	0.000302	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—MAT1A—type 2 diabetes mellitus	1.65e-05	0.000302	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—SREBF1—type 2 diabetes mellitus	1.64e-05	0.000301	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—type 2 diabetes mellitus	1.61e-05	0.000295	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—HMGCR—type 2 diabetes mellitus	1.6e-05	0.000292	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—ND1—type 2 diabetes mellitus	1.59e-05	0.000292	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—G6PC—type 2 diabetes mellitus	1.59e-05	0.000292	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—ENPP1—type 2 diabetes mellitus	1.59e-05	0.000292	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—HBA2—type 2 diabetes mellitus	1.59e-05	0.000292	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—PPP1R3C—type 2 diabetes mellitus	1.59e-05	0.000292	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—GCGR—type 2 diabetes mellitus	1.54e-05	0.000282	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—PTGDS—type 2 diabetes mellitus	1.53e-05	0.000279	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—AANAT—type 2 diabetes mellitus	1.53e-05	0.000279	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—OXCT1—type 2 diabetes mellitus	1.46e-05	0.000267	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—CYTB—type 2 diabetes mellitus	1.46e-05	0.000267	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—CDO1—type 2 diabetes mellitus	1.45e-05	0.000265	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—GPD2—type 2 diabetes mellitus	1.45e-05	0.000265	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—SRD5A1—type 2 diabetes mellitus	1.42e-05	0.00026	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—AK1—type 2 diabetes mellitus	1.38e-05	0.000252	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—STAR—type 2 diabetes mellitus	1.36e-05	0.000248	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—HSD17B3—type 2 diabetes mellitus	1.36e-05	0.000248	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—ACACA—type 2 diabetes mellitus	1.36e-05	0.000248	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—CBS—type 2 diabetes mellitus	1.3e-05	0.000238	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—ABCC8—type 2 diabetes mellitus	1.3e-05	0.000238	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—MAT1A—type 2 diabetes mellitus	1.27e-05	0.000233	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—SLC5A4—type 2 diabetes mellitus	1.27e-05	0.000233	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—COX2—type 2 diabetes mellitus	1.25e-05	0.000229	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—SLC5A2—type 2 diabetes mellitus	1.25e-05	0.000229	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—G6PC—type 2 diabetes mellitus	1.23e-05	0.000225	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—ENPP1—type 2 diabetes mellitus	1.23e-05	0.000225	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—HBA2—type 2 diabetes mellitus	1.23e-05	0.000225	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—ND1—type 2 diabetes mellitus	1.23e-05	0.000225	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—PPP1R3C—type 2 diabetes mellitus	1.23e-05	0.000225	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—NCOA6—type 2 diabetes mellitus	1.23e-05	0.000225	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	1.23e-05	0.000225	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—UCP3—type 2 diabetes mellitus	1.21e-05	0.000221	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—HSD11B1—type 2 diabetes mellitus	1.21e-05	0.000221	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—UCP2—type 2 diabetes mellitus	1.21e-05	0.000221	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—GCGR—type 2 diabetes mellitus	1.19e-05	0.000218	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	1.17e-05	0.000214	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—PCK1—type 2 diabetes mellitus	1.14e-05	0.000208	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—OXCT1—type 2 diabetes mellitus	1.13e-05	0.000206	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—CYTB—type 2 diabetes mellitus	1.13e-05	0.000206	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	1.12e-05	0.000205	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—SRD5A1—type 2 diabetes mellitus	1.1e-05	0.000201	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	1.09e-05	0.0002	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—HK1—type 2 diabetes mellitus	1.06e-05	0.000195	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	1.06e-05	0.000194	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	1.05e-05	0.000191	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	1.05e-05	0.000191	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	1.05e-05	0.000191	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—LPA—type 2 diabetes mellitus	1.03e-05	0.000188	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—HSD3B2—type 2 diabetes mellitus	1.03e-05	0.000188	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—GCKR—type 2 diabetes mellitus	1.03e-05	0.000188	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—KCNJ11—type 2 diabetes mellitus	1.03e-05	0.000188	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	1e-05	0.000183	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	1e-05	0.000183	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	9.88e-06	0.000181	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—ALDOB—type 2 diabetes mellitus	9.85e-06	0.00018	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	9.65e-06	0.000177	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	9.65e-06	0.000177	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	9.57e-06	0.000175	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	9.48e-06	0.000173	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	9.37e-06	0.000171	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	9.32e-06	0.000171	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	9.32e-06	0.000171	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	9.32e-06	0.000171	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	9.27e-06	0.000169	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—GLP1R—type 2 diabetes mellitus	9.16e-06	0.000167	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	8.77e-06	0.00016	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—SLC2A2—type 2 diabetes mellitus	8.55e-06	0.000156	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—MTR—type 2 diabetes mellitus	8.37e-06	0.000153	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—CPT1A—type 2 diabetes mellitus	8.37e-06	0.000153	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—NAMPT—type 2 diabetes mellitus	8.21e-06	0.00015	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	8.21e-06	0.00015	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	8.16e-06	0.000149	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—HBA1—type 2 diabetes mellitus	8.16e-06	0.000149	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—LIPC—type 2 diabetes mellitus	8.16e-06	0.000149	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—GCK—type 2 diabetes mellitus	8.16e-06	0.000149	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—CYP11A1—type 2 diabetes mellitus	8.11e-06	0.000148	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—SLC9A1—type 2 diabetes mellitus	7.97e-06	0.000146	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	7.93e-06	0.000145	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	7.93e-06	0.000145	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	7.93e-06	0.000145	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	7.93e-06	0.000145	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—CETP—type 2 diabetes mellitus	7.87e-06	0.000144	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	7.6e-06	0.000139	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	7.34e-06	0.000134	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—PSMD6—type 2 diabetes mellitus	7.32e-06	0.000134	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—SREBF1—type 2 diabetes mellitus	7.32e-06	0.000134	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—SNAP25—type 2 diabetes mellitus	7.32e-06	0.000134	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—CTGF—type 2 diabetes mellitus	7.18e-06	0.000131	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—HMGCR—type 2 diabetes mellitus	7.12e-06	0.00013	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	7.07e-06	0.000129	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	7.02e-06	0.000128	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—ADRA2A—type 2 diabetes mellitus	6.97e-06	0.000127	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—CYP2E1—type 2 diabetes mellitus	6.69e-06	0.000122	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—SLC2A1—type 2 diabetes mellitus	6.62e-06	0.000121	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	6.6e-06	0.000121	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	6.46e-06	0.000118	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	6.46e-06	0.000118	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—CYP3A4—type 2 diabetes mellitus	6.46e-06	0.000118	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	6.42e-06	0.000117	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—GCG—type 2 diabetes mellitus	6.35e-06	0.000116	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—SLC2A4—type 2 diabetes mellitus	6.35e-06	0.000116	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	6.34e-06	0.000116	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	6.3e-06	0.000115	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	6.3e-06	0.000115	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	6.3e-06	0.000115	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	6.26e-06	0.000114	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	6.15e-06	0.000112	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	6.08e-06	0.000111	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	5.65e-06	0.000103	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	5.65e-06	0.000103	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	5.65e-06	0.000103	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	5.54e-06	0.000101	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	5.5e-06	0.000101	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—PPARGC1A—type 2 diabetes mellitus	5.47e-06	0.0001	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—GNB3—type 2 diabetes mellitus	5.47e-06	0.0001	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—HMOX1—type 2 diabetes mellitus	5.44e-06	9.96e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	5.38e-06	9.84e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—CAT—type 2 diabetes mellitus	5.37e-06	9.83e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—APOB—type 2 diabetes mellitus	5.22e-06	9.54e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	5.17e-06	9.45e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	5.11e-06	9.34e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	5.11e-06	9.34e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—GSTM1—type 2 diabetes mellitus	5.07e-06	9.28e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—LPL—type 2 diabetes mellitus	4.98e-06	9.11e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	4.9e-06	8.96e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	4.9e-06	8.96e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—ADCY5—type 2 diabetes mellitus	4.88e-06	8.92e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—GPX1—type 2 diabetes mellitus	4.86e-06	8.89e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—CD36—type 2 diabetes mellitus	4.73e-06	8.65e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—PPP2CA—type 2 diabetes mellitus	4.67e-06	8.55e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—MTHFR—type 2 diabetes mellitus	4.48e-06	8.2e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—PPARA—type 2 diabetes mellitus	4.4e-06	8.05e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—AGT—type 2 diabetes mellitus	4.26e-06	7.79e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	4.22e-06	7.72e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.22e-06	7.72e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	4.2e-06	7.69e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—CALM1—type 2 diabetes mellitus	4.19e-06	7.66e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—APOE—type 2 diabetes mellitus	4.17e-06	7.64e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	4.15e-06	7.58e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—APOA1—type 2 diabetes mellitus	4.13e-06	7.55e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	4.03e-06	7.36e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	3.92e-06	7.16e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	3.84e-06	7.03e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	3.76e-06	6.88e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	3.75e-06	6.86e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	3.65e-06	6.68e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—PPARG—type 2 diabetes mellitus	3.64e-06	6.65e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	3.61e-06	6.6e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—INS—type 2 diabetes mellitus	3.57e-06	6.52e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	3.46e-06	6.33e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	3.39e-06	6.21e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	3.29e-06	6.01e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—ALB—type 2 diabetes mellitus	3.27e-06	5.98e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	3.23e-06	5.91e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	3.22e-06	5.89e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	3.18e-06	5.83e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—PIK3R1—type 2 diabetes mellitus	3.13e-06	5.72e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—NOS3—type 2 diabetes mellitus	3.13e-06	5.72e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—PTGS2—type 2 diabetes mellitus	2.86e-06	5.23e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	2.81e-06	5.13e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	2.75e-06	5.03e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	2.52e-06	4.62e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	2.41e-06	4.41e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	2.41e-06	4.41e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	2.21e-06	4.04e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—AKT1—type 2 diabetes mellitus	1.44e-06	2.63e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	1.11e-06	2.03e-05	CbGpPWpGaD
